In conclusion, our study explored the challenging landscape of the KRAS gene, emphasizing its intricate network and molecular heterogeneity across colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC) patients. The gene discussed is KRAS; the disease is pancreatic ductal adenocarcinoma.